Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study

NCT07263451 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DEVICE: IRE by stunning pulse therapy device

Sponsor

Tian'an Jiang